Search

Search Results
Results 4471 - 4480 of 4658 for Clear Cell Cancer
  • Elahere
    Drug - 2 Mar 2026
    Consumer Medicine Information (CMI) about Elahere intended for persons living in Australia.
  • Imfinzi
    Drug - 4 Feb 2026
    Consumer Medicine Information (CMI) about Imfinzi intended for persons living in Australia.
  • Protecting what’s vital: Cryo sample security
    White Paper - 28 Jan 2026
    A single equipment failure can quickly jeopardize vital cryo samples, creating a worst-case scenario for any lab.
  • Ngenla
    Drug - 23 Jan 2026
    Consumer Medicine Information (CMI) about Ngenla intended for persons living in Australia.
  • Why is cryopreservation needed for disaster prevention?
    White Paper - 16 Jan 2026
    Cryo-labs carry significant responsibility, safeguarding samples that, for many patients and researchers, are irreplaceable.
  • Actemra
    Drug - 16 Jan 2026
    Consumer Medicine Information (CMI) about Actemra intended for persons living in Australia.
  • Advancing PROTAC development through innovative preclinical model systems
    Health - 14 Jan 2026
    Innovative preclinical model systems are transforming PROTAC development by providing deeper insight into pharmacology.
  • January resolutions and how CO tracking helps smokers quit
    White Paper - 6 Jan 2026
    January is the top month to quit smoking, with CO tracking helping users stay committed.
  • Cresemba
    Drug - 30 Dec 2025
    Consumer Medicine Information (CMI) about Cresemba intended for persons living in Australia.
  • Velcade
    Drug - 16 Dec 2025
    Consumer Medicine Information (CMI) about Velcade intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback